IBDEI1B6 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23431,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23431,1,2,0)
 ;;=2^232.1
 ;;^UTILITY(U,$J,358.3,23431,1,5,0)
 ;;=5^Ca In Situ Eyelid
 ;;^UTILITY(U,$J,358.3,23431,2)
 ;;=^267726
 ;;^UTILITY(U,$J,358.3,23432,0)
 ;;=232.3^^148^1464^7
 ;;^UTILITY(U,$J,358.3,23432,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23432,1,2,0)
 ;;=2^232.3
 ;;^UTILITY(U,$J,358.3,23432,1,5,0)
 ;;=5^Ca In Situ Skin Temple
 ;;^UTILITY(U,$J,358.3,23432,2)
 ;;=^267728
 ;;^UTILITY(U,$J,358.3,23433,0)
 ;;=232.7^^148^1464^5
 ;;^UTILITY(U,$J,358.3,23433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23433,1,2,0)
 ;;=2^232.7
 ;;^UTILITY(U,$J,358.3,23433,1,5,0)
 ;;=5^Ca In Situ Skin Leg
 ;;^UTILITY(U,$J,358.3,23433,2)
 ;;=^267732
 ;;^UTILITY(U,$J,358.3,23434,0)
 ;;=232.0^^148^1464^6
 ;;^UTILITY(U,$J,358.3,23434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23434,1,2,0)
 ;;=2^232.0
 ;;^UTILITY(U,$J,358.3,23434,1,5,0)
 ;;=5^Ca In Situ Skin Lip
 ;;^UTILITY(U,$J,358.3,23434,2)
 ;;=^267725
 ;;^UTILITY(U,$J,358.3,23435,0)
 ;;=232.4^^148^1464^2
 ;;^UTILITY(U,$J,358.3,23435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23435,1,2,0)
 ;;=2^232.4
 ;;^UTILITY(U,$J,358.3,23435,1,5,0)
 ;;=5^Ca In Situ Scalp
 ;;^UTILITY(U,$J,358.3,23435,2)
 ;;=^267729
 ;;^UTILITY(U,$J,358.3,23436,0)
 ;;=232.8^^148^1464^9
 ;;^UTILITY(U,$J,358.3,23436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23436,1,2,0)
 ;;=2^232.8
 ;;^UTILITY(U,$J,358.3,23436,1,5,0)
 ;;=5^Ca In Situ Skin,Specified Site, Not Listed
 ;;^UTILITY(U,$J,358.3,23436,2)
 ;;=^267733
 ;;^UTILITY(U,$J,358.3,23437,0)
 ;;=198.2^^148^1465^1
 ;;^UTILITY(U,$J,358.3,23437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23437,1,2,0)
 ;;=2^198.2
 ;;^UTILITY(U,$J,358.3,23437,1,5,0)
 ;;=5^Secondary Skin Cancer
 ;;^UTILITY(U,$J,358.3,23437,2)
 ;;=^267333
 ;;^UTILITY(U,$J,358.3,23438,0)
 ;;=238.2^^148^1465^3
 ;;^UTILITY(U,$J,358.3,23438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23438,1,2,0)
 ;;=2^238.2
 ;;^UTILITY(U,$J,358.3,23438,1,5,0)
 ;;=5^Uncertain Behavior Neo Skin
 ;;^UTILITY(U,$J,358.3,23438,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,23439,0)
 ;;=239.2^^148^1465^4
 ;;^UTILITY(U,$J,358.3,23439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23439,1,2,0)
 ;;=2^239.2
 ;;^UTILITY(U,$J,358.3,23439,1,5,0)
 ;;=5^Unspecified Neoplasm
 ;;^UTILITY(U,$J,358.3,23439,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,23440,0)
 ;;=V76.43^^148^1465^2
 ;;^UTILITY(U,$J,358.3,23440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23440,1,2,0)
 ;;=2^V76.43
 ;;^UTILITY(U,$J,358.3,23440,1,5,0)
 ;;=5^Screening for malignant neoplasm
 ;;^UTILITY(U,$J,358.3,23440,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,23441,0)
 ;;=698.3^^148^1466^2
 ;;^UTILITY(U,$J,358.3,23441,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23441,1,2,0)
 ;;=2^698.3
 ;;^UTILITY(U,$J,358.3,23441,1,5,0)
 ;;=5^Prurigo Nodularis
 ;;^UTILITY(U,$J,358.3,23441,2)
 ;;=^70705
 ;;^UTILITY(U,$J,358.3,23442,0)
 ;;=698.2^^148^1466^1
 ;;^UTILITY(U,$J,358.3,23442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23442,1,2,0)
 ;;=2^698.2
 ;;^UTILITY(U,$J,358.3,23442,1,5,0)
 ;;=5^Prurigo
 ;;^UTILITY(U,$J,358.3,23442,2)
 ;;=^100043
 ;;^UTILITY(U,$J,358.3,23443,0)
 ;;=132.1^^148^1467^1
 ;;^UTILITY(U,$J,358.3,23443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23443,1,2,0)
 ;;=2^132.1
 ;;^UTILITY(U,$J,358.3,23443,1,5,0)
 ;;=5^Pediculosis, Body
 ;;^UTILITY(U,$J,358.3,23443,2)
 ;;=^266961
 ;;^UTILITY(U,$J,358.3,23444,0)
 ;;=132.0^^148^1467^2
 ;;^UTILITY(U,$J,358.3,23444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23444,1,2,0)
 ;;=2^132.0
 ;;^UTILITY(U,$J,358.3,23444,1,5,0)
 ;;=5^Pediculosis, Head
 ;;^UTILITY(U,$J,358.3,23444,2)
 ;;=^266960
